SCHEMBL21462829

SCHEMBL21462829

Cn1cc(-c2ccc(S(=O)(=O)n3ccc(/C=C(\C(N)=O)c4ccccc4N)c3)cc2)cn1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 4/20 0.65
▸ HDAC3 O15379 2/20 0.65
▸ HDAC2 Q92769 2/20 0.65
▸ KDM1A O60341 1/20 0.65
▸ HDAC10 Q969S8 1/20 0.65
▸ HDAC11 Q96DB2 1/20 0.65
▸ HDAC9 Q9UKV0 1/20 0.65
▸ CCNA2 P20248 3/20 0.40
▸ CDK2 P24941 3/20 0.40
▸ MKNK1 Q9BUB5 1/20 0.38
▸ MKNK2 Q9HBH9 1/20 0.38
▸ NAMPT P43490 1/20 0.37
▸ KLKB1 P03952 1/20 0.37
▸ EP300 Q09472 2/20 0.37
▸ HDAC6 Q9UBN7 2/20 0.37
▸ HDAC8 Q9BY41 1/20 0.36
▸ CCNC P24863 2/20 0.35
▸ CDK8 P49336 2/20 0.35
▸ CA1 P00915 1/20 0.35
▸ CA2 P00918 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21462830 1.00 HDAC1 (0.65) HDAC1HDAC3HDAC2KDM1AHDAC10
Hydrochloric Acid SCHEMBL3434610 0.99 HDAC1 (0.64) HDAC1HDAC3HDAC2KDM1AHDAC10
Hydrochloric Acid SCHEMBL3434603 0.99 HDAC1 (0.64) HDAC1HDAC3HDAC2KDM1AHDAC10
SCHEMBL1613971 0.81 HDAC3 (0.61) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL30477018 0.79 HDAC1 (1.00) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL1613943 0.79 HDAC1 (1.00) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL1613939 0.79 HDAC1 (1.00) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL1614665 0.78 HDAC1 (0.98) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL1613921 0.78 HDAC1 (0.98) HDAC1HDAC3HDAC2KDM1AHDAC10
Domatinostat SCHEMBL1614634 0.78 HDAC1 (0.98) HDAC1HDAC3HDAC2KDM1AHDAC10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3781557-A1 PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER 4SC AG (DE) 2021-02-24 — — EP disclosed
WO-2019197682-A1 PHARMACEUTICAL COMBINATION PRODUCTS COMPRISING A HISTONE DEACETYLASE (HDAC) INHIBITOR AND A TLR7 AGONIST AND/OR TLR8 AGONIST FOR THE TREATMENT OF CANCER 4SC AG (DE) 2019-10-17 — — WO disclosed
Send feedback